The global Biosimilars Market , valued at US$32.75 billion in 2024 stood at US$35.04 billion in 2025 and is projected to ...

More than two dozen congressional Democrats have signed on to a new bill aimed at injecting transparency into funding for ...

Health care stocks have outperformed so far in 2025 despite uncertainty surrounding the Donald Trump administration's policies. Health care stocks can often be a solid defensive play in an ...

Amgen is set to release its second-quarter earnings next month, and analysts are projecting modest single-digit growth in ...

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

CWM LLC raised its stake in Amgen by 8% in Q1, buying 11,175 more shares worth nearly $47 million. Other institutional ...

More than thirty years since its 1993 founding, Catherine Owen Adams and Elizabeth Thompson—the R&D combo that has led Acadia ...

Amgen (AMGN) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Amgen combines patent protection, a robust pipeline, and strong execution for defensive investment. Click here to read an ...

Shares of The Trade Desk received a nice bump in after-hours trading on July 14 after it was announced that the ad-tech company would be joining the S&P 500 beginning on July 18. The Trade Desk, which ...

There's one main way to treat inflammatory bowel disease (IBD): Control inflammation by whipping the immune system into shape ...

It’s called the Amgen Biotech Experience and for a number of teachers across the Piedmont, it could be the key to helping ...